Search Results - "Duchenne muscular dystrophy"

Xp21 Contiguous Gene Deletion Syndrome: Diagnosis, Treatment, and a Review of the Literature on a Rare Genetic Disorder.

Authors: Singin, Berna Donbaloğlu, Zeynep Çetiner, Ebru Barsal et al.

Source: Journal of Clinical Research in Pediatric Endocrinology. 2026 Suppl, Vol. 18, p83-91. 9p.

Incremental Disease Burden (Healthcare Costs and Resources) of Duchenne Muscular Dystrophy in the US: A Matched Cohort Analysis.

Authors: Scavina, Mena Posner, Nate Dorling, Patricia et al.

Source: PharmacoEconomics - Open. May2026, Vol. 10 Issue 3, p491-501. 11p.

Conformable Microelectrode Arrays Integrated with a Scoop‐Shaped Slide‐Well for Dynamic Electrophysiological Profiling of Patient‐Derived Cardiac Organoids.

Authors: Kim, Ye Seul Jeong, Jeonghwa Heo, Gyeonghwa et al.

Source: Advanced Science. 6/4/2026, Vol. 13 Issue 31, p1-16. 16p.

Management of Duchenne Muscular Dystrophy in Clinical Practice: A Survey-Based Study in Spain.

Authors: Ortez, Carlos Branas-Pampillón, María Fernandez, Joaquín Alejandro et al.

Source: Neurology & Therapy. Jun2026, Vol. 15 Issue 3, p1033-1042. 10p.

Repurposing Empagliflozin for Duchenne Muscular Dystrophy-Associated Cardiomyopathy: Protocol for a Pharmacokinetics, Safety and Proof-of-Concept Trial in Children.

Authors: Lava, Sebastiano A. G. Laurence, Craig Mallory, Janet et al.

Source: Cardiology & Therapy. May2026, p1-12. 12p.

Gene Editing Strategies for Duchenne Muscular Dystrophy: From Molecular Mechanisms to Clinical Translation.

Authors: Siddika, Ayesha Rousseau, Joël Veillette, Félix et al.

Source: Cells (2073-4409). May2026, Vol. 15 Issue 10, p852. 32p.

Clinical and epidemiological profile of patients with Duchenne muscular dystrophy in a tertiary care pediatric hospital in Mexico.

Alternate Title: Perfil clínico y epidemiológico de pacientes con distrofia muscular de Duchenne en un hospital pediátrico de tercer nivel de atención en México.

Authors: Múnera-Libreros, Rosa H. Ruiz-García, Matilde Sanchez-Vargas, Jorge

Source: Revista Mexicana de Neurociencia. May/Jun2026, Vol. 27 Issue 3, p110-117. 8p.

Reliability and discriminative validity of single- and dual-task 10-meter walk test for assessing cognitive-motor interference in children with Duchenne muscular dystrophy.

Authors: Kurt-Aydin, Merve Savas-Kalender, Dilan Acarol, Fatma Ozden et al.

Source: Physiotherapy Theory & Practice. Apr2026, p1-10. 10p.

Overlapping phenotype of GNE myopathy and dystrophinopathy: a rare case with dual variants from India.

Authors: Halder, Tamali Joshi, Deepika Das, Parimal

Source: Journal of Rare Diseases. 4/6/2026, Vol. 5 Issue 1, p1-8. 8p.

A natural history study of Chinese individuals with Duchenne muscular dystrophy: Results from 2 years of follow-up and beyond.

Authors: Li, Xihua Yang, Xinying Chang, Xingzhi et al.

Source: PLoS ONE. 4/2/2026, Vol. 21 Issue 4, p1-14. 14p.

Effectiveness of Telerehabilitation on Pulmonary Function in Children with Duchenne Muscular Dystrophy: A Pre-Post Intervention Study.

Authors: Gupta, Priyanka Bali, Seveka Sood, Amrit Pal Singh et al.

Source: Journal of Modern Rehabilitation. Apr2026, Vol. 20 Issue 2, p158-165. 8p.

Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK Trial.

Authors: Mendell, Jerry R. Muntoni, Francesco McDonald, Craig M. et al.

Source: Neurology & Therapy. Apr2026, Vol. 15 Issue 2, p545-559. 15p.

RNA Therapeutics for Duchenne Muscular Dystrophy: Exon Skipping, RNA Editing, and Translational Insights from Genome-Edited Microminipig Models.

Authors: Chassin, Alex Ono, Hiroya Ashida, Yuki et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 6, p2755. 24p.

Duchenne Muscular Dystrophy: Contemporary Therapeutic Options and Real-World Challenges in Treatment Selection.

Authors: Pesco, Maria Tozzo Öztürk, Gülru Zeynep Bhadola, Shivkumar C. et al.

Source: Muscles (2813-0413). Mar2026, Vol. 5 Issue 1, p21. 16p.

Vamorolon pro léčbu Duchennovy svalové dystrofie.

Alternate Title: Vamorolone for treatment of Duchenne muscular dystrophy.

Authors: Rohlenová, M. (AUTHOR)

Source: Česká a Slovenská Neurologie a Neurochirurgie. 2026, Vol. 89 Issue 2, p87-92. 6p.

Research progress on the application of virtual reality technology in patients with Duchenne muscular dystrophy.

Authors: Liu, Shuting Wang, Xiaokang Ren, Yahao et al.

Source: International Journal of Neuroscience. Feb2026, Vol. 136 Issue 2, p213-217. 5p.

Subjects: Duchenne muscular dystrophy, Virtual reality, Treatment effectiveness, Therapeutics, Disease complications, Muscular dystrophy, Rehabilitation

Macrophage Infiltration, Activation, and Therapeutic Implication in Skeletal Muscle Injury and Repair.

Authors: Wang, Xingyu Zhou, Lan

Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 3, p1332. 18p.

Rare DMD Gene Duplication in a Lebanese Child With Duchene Muscular Dystrophy.

Authors: Assaf, Nada El Hajj, Jeanette Doghman, Jana et al.

Source: Clinical Case Reports. Feb2026, Vol. 14 Issue 2, p1-5. 5p.

Caregiver-reported Patient Experiences with Duchenne Muscular Dystrophy: Qualitative In-trial Interviews 1 Year After Delandistrogene Moxeparvovec in the Pivotal EMBARK Trial.

Authors: Audhya, Ivana Nacson, Alise B. Gooch, Katherine et al.

Source: Neurology & Therapy. Feb2026, Vol. 15 Issue 1, p41-60. 20p.

Twisting Paths: The Paradox of Fiber Branching in Muscle Regeneration.

Authors: Kiriaev, Leonit North, Kathryn N. Head, Stewart I. et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 2, p684. 24p.